For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place where researchers have developed new therapies in-house and published ...

Genentech raised nearly $2 billion during its second initial public offering (IPO) on July 20 when Roche Holding refloated part of the company after acquiring all outstanding shares in June ...

A four-year battle over one of the most ubiquitous patents in biotech ended with the US Patent and Trademark Office (USPTO) coming down on Genentech's side. The decision, reached in February ...

On Genentech's website, the company notes that its large South San Francisco campus encompasses scientific research, manufacturing and “various business functions.” Earlier this month ...

This announcement comes as a major surprise in the scientific community. Genentech was founded in 1976 by Robert Swanson and Dr. Herbert Boyer. According to Genentech’s website, Swanson reached out to ...

Is Genentech losing its zest for innovation? Genentech has long been known for innovation, but that reputation has been questioned in the wake of multiple rounds of layoffs and the company’s ...

Genentech, the biotechnology giant, announced Monday it would invest $10 million in a nationwide K-12 school STEM program that originated in South San Francisco schools. The program, Futurelab+, ...

Genentech has received Food and Drug Administration approval for its treatment of certain types of lung, liver, skin and soft tissue cancer in adults. The treatment, called Tecentriq Hybreza, can ...

Roche’s Genentech unit signed a trio of deals this week to add new drug discovery platforms to its repertoire. The three drug discovery deals are with Convelo Therapeutics in neurological ...

Genentech disclosed in regulatory filings this week that it will lay off 436 employees at its South San Francisco ...

Genentech, a drugmaker based in South San Francisco, is laying off 93 more local workers just months after a 436-worker cut. The company, which is owned by Swiss pharmaceutical giant Roche ...